Kyoto, Japan

Junji Yodoi

This inventor holds 1 USPTO granted patent. Top assignees: Ajinomoto Co., Ltd., Other. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Junji Yodoi. Retrieved from https://idiyas.com/inventor/junji-yodoi-qvw3kzyt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:

goldMedal1 out of 1,953 
 
Ajinomoto Co., Ltd.
 patents
silverMedal1 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Junji Yodoi: Innovator in Cancer Therapy

Introduction

Junji Yodoi is a prominent inventor based in Sakyo-ku, Japan. He has made significant contributions to the field of medical science, particularly in cancer therapy. His innovative approach has led to the development of a unique method for treating radiation damage and other related health issues.

Latest Patents

Junji Yodoi holds 1 patent for his invention titled "Method for treating cancer therapy radiation damage or arteriosclerosis." This patent discloses a composition and method for treating inflammation, rheumatism, autoimmune diseases, ischemic damage of organs, drug toxicity, and arteriosclerosis, utilizing human ADF.

Career Highlights

Throughout his career, Junji Yodoi has worked with notable companies, including Ajinomoto Co., Ltd. His work has been instrumental in advancing therapeutic methods that address critical health challenges.

Collaborations

Junji Yodoi has collaborated with esteemed colleagues such as Atsushi Uchida and Yutaka Tagaya. Their combined expertise has contributed to the success of his innovative projects.

Conclusion

Junji Yodoi's contributions to cancer therapy and related fields highlight his role as a significant inventor. His work continues to inspire advancements in medical treatments and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…